Twin Health's AI Digital Twin Outperforms Traditional Diabetes Care
Twin Health's AI Digital Twin technology has been validated by the Validation Institute for its superior performance in managing type 2 diabetes, pre-diabetes, obesity, and related chronic conditions, announced in a press release. The technology significantly reduces A1C levels, facilitates safe deprescribing of medications, and supports sustained weight loss.
The AI Digital Twin creates a personalized digital replica of each user's metabolism, allowing for precision interventions that improve various health metrics, including blood pressure and cholesterol levels. This approach has been validated in a randomized controlled trial published in the New England Journal of Medicine Catalyst.
Twin Health is the first metabolic health vendor to achieve such validation, setting a new standard of care for diabetes and obesity management. The company's model aligns financial incentives with measurable clinical outcomes, offering significant savings for employers and health plans.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 Truven launches MarketScan Snapshot for healthcare data checks Sep 29 Omega Healthcare Wins Gold in 2026 AI Breakthrough Awards Sep 29 Phylo Launches Target Atlas for Drug Target Prioritization Sep 29 ChromAgeNet Detects Aging Signs in Blood Stem Cell Images Sep 29 Axxess Partners With Eazewell for Hospice Family SupportLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Atman Health Wins ARPA-H Award to Build Heart Failure AI
Linearis Joins Two Canadian AI Health Data Projects
CIPRA.ai and Murata Explore AI Wearables for Chronic Care
Nuna Health Offers Eligible Medicare Beneficiaries Free AI Health Coaching
Dimer Health Launches AiME for Post Discharge Care
Daily AI Brief: the AI news that matters, in your inbox.